599 related articles for article (PubMed ID: 16328181)
21. ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
Oparil S; Kjeldsen SE; Hedner T; Narkiewicz K
Blood Press; 2009; 18(1-2):4-6. PubMed ID: 19191085
[No Abstract] [Full Text] [Related]
22. The role of angiotensin receptor blockers in diabetic nephropathy.
Sharma AM; Weir MR
Postgrad Med; 2011 May; 123(3):109-21. PubMed ID: 21566421
[TBL] [Abstract][Full Text] [Related]
23. Initial combination therapy compared with monotherapy in diabetic hypertensive patients.
Sowers JR; Lastra G; Rocha R; Seifu Y; Crikelair N; Levy DG
J Clin Hypertens (Greenwich); 2008 Sep; 10(9):668-76. PubMed ID: 18844761
[TBL] [Abstract][Full Text] [Related]
24. [AT-1 blockers are different in their effects. The forgetful patients begin to notice it especially].
MMW Fortschr Med; 2003 Apr; 145(15):62. PubMed ID: 15104271
[No Abstract] [Full Text] [Related]
25. Improving microvascular outcomes in patients with diabetes through management of hypertension.
McGill JB
Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
[TBL] [Abstract][Full Text] [Related]
26. Beyond ONTARGET: angiotensin-converting enzyme inhibition and angiotensin II receptor blockade in combination, a lesser evil in some?
Wong J; Molyneaux L; Constantino M; Twigg SM; Yue DK
Diabetes Obes Metab; 2010 Dec; 12(12):1072-8. PubMed ID: 20977578
[TBL] [Abstract][Full Text] [Related]
27. [Valsartan: arguments for the high dose concept].
MMW Fortschr Med; 2006 Dec; 148(51-52):54-5. PubMed ID: 17619348
[No Abstract] [Full Text] [Related]
28. Valsartan. Just a second-line antihypertensive drug.
Can Fam Physician; 1999 Nov; 45():2626-8, 2630-3. PubMed ID: 10587770
[TBL] [Abstract][Full Text] [Related]
29. [The kidney as a target organ in diabetic patients with arterial hypertension].
Viberti G
Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
[TBL] [Abstract][Full Text] [Related]
30. [Microalbuminuria as a warning sign of diabetic nephropathy. Test your diabetics early!].
Dietrich W; Blumenstein M
MMW Fortschr Med; 2003 Mar; 145(10):40-2. PubMed ID: 12688026
[No Abstract] [Full Text] [Related]
31. [Hypertension therapy for type 2 diabetics].
Bönner G
MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
[No Abstract] [Full Text] [Related]
32. [Hypertensive patients have to be doubly treated earlier. Which antihypertensive drug combination is appropriate to whom?].
MMW Fortschr Med; 2003 May; 145(22):56. PubMed ID: 12866285
[No Abstract] [Full Text] [Related]
33. [Treatment of hypertension in patients with adult-onset diabetes].
Mykkänen L
Duodecim; 1999; 115(10):1147-53. PubMed ID: 11877854
[No Abstract] [Full Text] [Related]
34. [Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects].
Zukowska-Szczechowska E; Tomaszewski M; Grzeszczak W
Przegl Lek; 2001; 58(3):124-6. PubMed ID: 11475857
[TBL] [Abstract][Full Text] [Related]
35. [New effective dosage of valsartan. High dosage--effective against high blood pressure].
MMW Fortschr Med; 2007 Nov; 149(46):52-3. PubMed ID: 18069195
[No Abstract] [Full Text] [Related]
36. [VALUE study underscores the significance of reaching aimed blood pressure values for minimizing cardiovascular risks].
Praxis (Bern 1994); 2004 Oct; 93(42):1748. PubMed ID: 15529964
[No Abstract] [Full Text] [Related]
37. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
He YL; Ligueros-Saylan M; Sunkara G; Sabo R; Zhao C; Wang Y; Campestrini J; Pommier F; Dole K; Marion A; Dole WP; Howard D
J Clin Pharmacol; 2008 Jan; 48(1):85-95. PubMed ID: 17986525
[TBL] [Abstract][Full Text] [Related]
38. [VALISH].
Rakugi H; Ogihara T
Nihon Rinsho; 2006 Aug; 64 Suppl 6():454-8. PubMed ID: 16981579
[No Abstract] [Full Text] [Related]
39. [Diabetes and Nephropathy: ACE inhibitor for type 1, AT1 blocker for type 2].
Zidek W
MMW Fortschr Med; 2004 Oct; 146(42):51-2. PubMed ID: 15536706
[No Abstract] [Full Text] [Related]
40. [Dangerous duo: hypertension and pre-diabetes--the underestimated risk].
MMW Fortschr Med; 2003 Jan; 145(3-4):54-5. PubMed ID: 12619235
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
